Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial

Qiao-ning Yang; Rui-na Bai; Guo-ju Dong; Chang-jiang Ge; Jing-min Zhou; Li Huang; Yan He; Jun Wang; Ai-hua Ren; Zhan-quan Huang; Guang-li Zhu; Shu Lu; Shang-quan Xiong; Shao-xiang Xian; Zhi-jun Zhu; Da-zhuo Shi; Shu-zheng Lu; Li-zhi Li; Ke-ji Chen

doi:10.1007/s11655-018-2833-5

Your Location：

Home >

Browse articles >

Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial

Updated：2021-08-27

- Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial
- Chinese Journal of Integrative Medicine Vol. 24, Issue 5, Pages: 336-342(2018)
- Affiliations：
  
  1. Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
  2. Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Respiratory Medicine, Capital Medical University,Beijing,China
  3. Department of Cardiology, Zhongshan Hospital, Fudan University,Shanghai,China
  4. Department of Cardiology, China-Japan Friendship Hospital,Beijing,China
  5. Department of Cardiology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shaihai,China
  6. Department of Cardiology, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine,Hangzhou,China
  7. Department of Cardiology, Zhejiang Hospital,Hangzhou,China
  8. Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou,China
  9. Department of Cardiology, Guangxing Hospital Affiliated to Zhejiang Chinese Medical University,Hangzhou,China
  10. Department of Cardiology, Wuxi Traditional Chinese Medicine Hospital, Nanjing University of Traditional Chinese Medicine,Wuxi,China
  11. Department of Cardiology, People’s Hospital Affiliated Fujian University of Traditional Chinese Medicine,Fuzhou,China
  12. Department of Cardiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou,China
  13. Department of Cardiology, The 117th Hospital of People’s Liberation Army of China,Hangzhou,China
- Author bio：
- Funds：
  
  Supported by the Traditional Chinese Medicine Public Welfare Scientific Research Project, State Administration of Traditional Chinese Medicine of China (No. 201007001)
- DOI：10.1007/s11655-018-2833-5
  CLC：
- Published：2018，
  
  Published Online：13 February 2018，
Scan for full text
Yang, Qn., Bai, Rn., Dong, Gj. et al. Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial., Chin. J. Integr. Med. 24, 336–342 (2018). https://doi.org/10.1007/s11655-018-2833-5

Qiao-ning Yang, Rui-na Bai, Guo-ju Dong, et al. Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial. [J]. Chinese Journal of Integrative Medicine 24(5):336-342(2018)
Yang, Qn., Bai, Rn., Dong, Gj. et al. Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial., Chin. J. Integr. Med. 24, 336–342 (2018). https://doi.org/10.1007/s11655-018-2833-5 DOI：

Qiao-ning Yang, Rui-na Bai, Guo-ju Dong, et al. Effect of Kuanxiong Aerosol (宽胸气雾剂) on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial. [J]. Chinese Journal of Integrative Medicine 24(5):336-342(2018) DOI： 10.1007/s11655-018-2833-5.

摘要

To evaluate the effect and safety of Kuanxiong Aerosol (宽胸气雾剂

KA) on patients with angina pectoris. Block randomization was performed to randomly allocate 750 patients into KA (376 cases) and control groups (374 cases). During an angina attack

the KA group received 3 consecutive sublingual sprays of KA (0.6 mL per spray). The control group received 1 sublingual nitroglycerin tablet (NT

0.5 mg/tablet). Log-rank tests and Kaplan-Meier estimations were used to estimate the angina remission rates at 6 time-points after treatment (1

and >5 min). Logistic regression analysis was performed to observe the factors inflfluencing the rate of effective angina remission

and the remission rates and incidences of adverse reactions were compared for different Canadian Cardiovascular Society (CCS) classes of angina. The 5-min remission rates in the KA and control groups were not signifificantly different (94.41% vs. 90.64%

P>0.05). The angina CCS class signifificantly inflfluenced the rate of remission (95% confidence interval = 0.483–0.740

P<0.01). In the CCS subgroup analysis

the 3-and 5-min remission rates for KA and NT were similar in the CCSII and III subgroups (P>0.05)

while they were signifificantly better for KA in the CCSI and II subgroups (P<0.05 or P<0.01). Furthermore

the incidence of adverse reactions was signifificantly lower in the KA group than in the control group for the CCSII and III subgroups (9.29% vs. 26.22%

10.13% vs. 20.88%

P<0.05 or P<0.01). KA is not inferior to NT in the remission of angina. Furthermore

in CCSII and III patients

KA is superior to NT

with a lower incidence of adverse reactions. (Registration No. ChiCTRIPR-15007204)

Abstract

To evaluate the effect and safety of Kuanxiong Aerosol (宽胸气雾剂

KA) on patients with angina pectoris. Block randomization was performed to randomly allocate 750 patients into KA (376 cases) and control groups (374 cases). During an angina attack

the KA group received 3 consecutive sublingual sprays of KA (0.6 mL per spray). The control group received 1 sublingual nitroglycerin tablet (NT

0.5 mg/tablet). Log-rank tests and Kaplan-Meier estimations were used to estimate the angina remission rates at 6 time-points after treatment (1

and >5 min). Logistic regression analysis was performed to observe the factors inflfluencing the rate of effective angina remission

P>0.05). The angina CCS class signifificantly inflfluenced the rate of remission (95% confidence interval = 0.483–0.740

P<0.01). In the CCS subgroup analysis

the 3-and 5-min remission rates for KA and NT were similar in the CCSII and III subgroups (P>0.05)

while they were signifificantly better for KA in the CCSI and II subgroups (P<0.05 or P<0.01). Furthermore

the incidence of adverse reactions was signifificantly lower in the KA group than in the control group for the CCSII and III subgroups (9.29% vs. 26.22%

10.13% vs. 20.88%

P<0.05 or P<0.01). KA is not inferior to NT in the remission of angina. Furthermore

in CCSII and III patients

KA is superior to NT

with a lower incidence of adverse reactions. (Registration No. ChiCTRIPR-15007204)

关键词

Kuanxiong Aerosolangina pectorisCanadian Cardiovascular Society classification of anginarandomized controlled trialChinese Medicine

Keywords

Kuanxiong Aerosolangina pectorisCanadian Cardiovascular Society classification of anginarandomized controlled trialChinese Medicine

references

Chinese Society of Cardiology of Chinese Medical Association. Guideline for diagnosis and treatment of patients with chronic stable angina. Chin J Cardiol (Chin) 2007;35:195-206.

Chinese Society of Cardiology of Chinese Medical Association. Guideline for diagnosis and treatment of patients with unstable angina and non-ST-segment elevation myocardial infarction. Chin J Cardiol (Chin) 2007;35:295-304.

Cardiovascular Disease Study Group, Xiyuan Hospital of China Academy of Chinese Medical Sciences. Observation of pain relief by Kuanxiong Aerosol in acute angina attacks. J Tradit Chin Med (Chin) 1973;23:14-16.

Cardiovascular Research Laboratory and Pharmacology Group, Xiyuan Hospital of China Academy of Chinese Medical Sciences. Observations on the immediate effects of Kuanxiong Aerosol on angina attacks. Chin J Integr Tradit West Med (Chin) 1981;1:9,18,61.

Guo SK, Chen KJ, Weng WL, Zhang WQ, Yu YQ. Immediate effect of Kuanxiong Aerosol in the treatment of angina attacks. Planta Med 1983;47:116.

Li L, Li CY, Gu H, Mao JS, Shao MJ, Li YJ, Huang L. Clinical observation of Kuanxiong Aerosol in the treatment of coronary heart disease angina. Inf Tradit Chin Med (Chin) 2014;31:131–133.

Dai J, Ge CJ, Tian JF, Lu SZ. Clinical observation of Kuanxiong Aerosol in the treatment of angina. Inf Tradit Chin Med (Chin) 2014;31:135–136.

Fang JY, Wang Z. Clinical observations of Kuanxiong Aerosol in the improvement of electrocardiogram changes in acute angina in patients with coronary heart disease. Chin J Integr Med Cardio Cerebrovasc Dis (Chin) 2015;13:223–224.

Li LZ, Dong GJ, Ge CJ, Zhou JM, Huang L, He Y, et al. Effect of Kuanxiong Aerosol on coronary heart disease angina patients: a multicenter randomized controlled clinical study. Chin J Integr Tradit West Med (Chin) 2014;34:396–401.

Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol 2002;18:371–379.

Zheng XY, ed. Guiding principles for the clinical study of new Chinese medicines. Beijing: Chinese Medical Science Press;2002:69–70.

China State Food and Drug Administration. Technique guidelines for Chinese medicine and herb clinical research on angina and menonpausal syndrome. Available at http://www.sfda.gov.cn/WS01/CL1036/64117.html

Liu LT, Chen KJ. Ancient and modern application of aromatic herbs for activating yang in preventing and treating coronary heart disease angina. Chin J Integr Tradit West Med (Chin) 2013;33:1013–1017.

Chen XY, Gao Y, Li WM. CS-MS analysis of the chemical composition of commercial sandalwood volatile oils. J Chin Med Mater (Chin) 2012;35:418–421.

Cheng L. Identification and pharmacological effects of Asarum. Strait Pharm J (Chin) 2008;20:68–70.

Liu JG, Cui J, Liu ZQ. Effect of Kuanxin Zhitong Plaster on experimental microcirculatory disorders. Chin J Microcirc (Chin) 1995;5:43–44.

Wang BJ, Dong GJ, Liu JG, Duan WH, Jiang YR, Wang P, et al. The relieving effects of Kuanxiong Aerosol on angina pectoris and its influences on endothelial function index in patients with coronary heart disease. J Emerg Tradit Chin Med (Chin) 2015;24:2175–2178.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effect of Shenzhu Guanxin Recipe (参术冠心方) on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial

A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism

Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials

Efficacy of externally applied Chinese herbal drugs in treating psoriasis: A systematic review

Contemporary treatment of Western and Chinese medicine for cardiac syndrome X

Related Author

No data

Related Institution

Cardiovascular Department, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences

Postdoctoral Mobile Research Station, Guangzhou University of Traditional Chinese Medicine

Cardiovascular Department of Ershadao Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

Cardiac Surgeon Department of University Town Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

Cardiovascular Department of Fangcun Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰